Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by LPL Financial LLC

LPL Financial LLC increased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 5.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 75,757 shares of the company’s stock after buying an additional 3,967 shares during the period. LPL Financial LLC’s holdings in Doximity were worth $4,045,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC raised its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. increased its stake in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC raised its position in shares of Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after purchasing an additional 250 shares during the last quarter. Optimum Investment Advisors purchased a new position in Doximity in the 4th quarter valued at about $43,000. Finally, Morse Asset Management Inc acquired a new stake in Doximity in the 3rd quarter worth about $46,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

NASDAQ:DOCS opened at $51.52 on Friday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The company has a 50 day moving average price of $64.86 and a 200 day moving average price of $55.41. The stock has a market capitalization of $9.62 billion, a P/E ratio of 51.52, a PEG ratio of 4.10 and a beta of 1.41.

Analysts Set New Price Targets

A number of equities analysts have commented on DOCS shares. Mizuho increased their target price on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and increased their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Raymond James restated an “outperform” rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Bank of America increased their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Finally, Leerink Partnrs upgraded Doximity from a “hold” rating to a “strong-buy” rating in a report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $64.72.

Insiders Place Their Bets

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 37.40% of the stock is owned by insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.